88 related articles for article (PubMed ID: 7863443)
1. [The endocrine status of men with lupus nephritis].
Kukhtevich AV; Ianushkevich TN; Adnoral SA; Gitel' EP
Ter Arkh; 1994; 66(10):33-5. PubMed ID: 7863443
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?
Wetzels JF
Neth J Med; 2004 Nov; 62(10):347-52. PubMed ID: 15683089
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience.
Liang L; Yang X; Xu H; Zhan Z; Ye Y; Yu X; Chen W
J Rheumatol; 2004 Apr; 31(4):701-6. PubMed ID: 15088294
[TBL] [Abstract][Full Text] [Related]
5. Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus.
Silva CA; Hallak J; Pasqualotto FF; Barba MF; Saito MI; Kiss MH
J Rheumatol; 2002 Sep; 29(9):2000-5. PubMed ID: 12233898
[TBL] [Abstract][Full Text] [Related]
6. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
7. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
9. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
[TBL] [Abstract][Full Text] [Related]
10. Beyond immunosuppression - challenges in the clinical management of lupus nephritis.
Masood S; Jayne D; Karim Y
Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111
[TBL] [Abstract][Full Text] [Related]
11. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
12. Reproductive function in patients with renal insufficiency.
Lim VS
Am J Kidney Dis; 1987 Apr; 9(4):363-7. PubMed ID: 3555011
[TBL] [Abstract][Full Text] [Related]
13. [Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?].
Noldus J; Huland H
Urologe A; 1994 Jan; 33(1):73-5. PubMed ID: 8146936
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of uremic hypogonadism with parlodel].
Kukhtevich AV; Ermolenko VM; Dedov II; Mel'nichenko GA; Gitel' EP
Ter Arkh; 1985; 57(12):39-41. PubMed ID: 4089767
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunction in uremia. Endocrine and neurological alterations.
Campese VM; Liu CL
Contrib Nephrol; 1990; 77():1-14. PubMed ID: 2188780
[No Abstract] [Full Text] [Related]
17. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
18. [The effect of low-intensity laser radiation on spermatogenesis in men].
Kovalev EV
Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (5):33-6. PubMed ID: 2281618
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
